<SUBMISSION>
<ACCESSION-NUMBER>0001144204-12-013292
<TYPE>SC 14D9/A
<PUBLIC-DOCUMENT-COUNT>2
<FILING-DATE>20120306
<DATE-OF-FILING-DATE-CHANGE>20120306
<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME>ATS CORP
<CIK>0001325460
<ASSIGNED-SIC>8742
<IRS-NUMBER>113747950
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>SC 14D9/A
<ACT>34
<FILE-NUMBER>005-81087
<FILM-NUMBER>12670893
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7925 JONES BRANCH DRIVE
<CITY>MCLEAN
<STATE>VA
<ZIP>22102
<PHONE>571-766-2400
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7925 JONES BRANCH DRIVE
<CITY>MCLEAN
<STATE>VA
<ZIP>22102
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>Federal Services Acquisition CORP
<DATE-CHANGED>20050429
</FORMER-COMPANY>
</SUBJECT-COMPANY>
<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME>ATS CORP
<CIK>0001325460
<ASSIGNED-SIC>8742
<IRS-NUMBER>113747950
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>SC 14D9/A
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7925 JONES BRANCH DRIVE
<CITY>MCLEAN
<STATE>VA
<ZIP>22102
<PHONE>571-766-2400
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7925 JONES BRANCH DRIVE
<CITY>MCLEAN
<STATE>VA
<ZIP>22102
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>Federal Services Acquisition CORP
<DATE-CHANGED>20050429
</FORMER-COMPANY>
</FILED-BY>
<DOCUMENT>
<TYPE>SC 14D9/A
<SEQUENCE>1
<FILENAME>v304898_sc14d9a.htm
<DESCRIPTION>AMENDMENT TO SCHEDULE 14D-9
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 14D-9</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SOLICITATION/RECOMMENDATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>STATEMENT UNDER SECTION 14(d)(4) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>(Amendment No. 1)</B></P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ATS Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>(Name of Subject Company)</I></P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ATS Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>(Name of Person Filing Statement)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>COMMON STOCK, PAR VALUE $0.0001 PER SHARE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>(Title of Class of Securities)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>00211E104</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>(CUSIP Number of Class of Securities)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pamela Little</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Co-Chief Executive Officer and Chief Financial
Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ATS Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>7925 Jones Branch Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>McLean, VA 22102</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Telephone: (571) 766-2400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Name, address and telephone numbers of person
authorized to receive notices and</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>communications on behalf of the persons filing
statement)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>With copies to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Squire Sanders (US) LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>1200 19<SUP>th</SUP> Street, NW<BR>
Suite 300<BR>
Washington, D.C. 20036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Attention: James J. Maiwurm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Telephone: (202) 696-6600</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23.75pt"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Check
the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Amendment No.1 (this
&ldquo;Amendment&rdquo;) amends the Solicitation/Recommendation Statement on Schedule 14D-9 (as amended or supplemented from
time to time, the &ldquo;Schedule 14D-9&rdquo;) originally filed with the U.S. Securities and Exchange Commission (the
&ldquo;SEC&rdquo;) by ATS Corporation, a Delaware corporation (the &ldquo;Company&rdquo;) on February 29, 2012. This
Amendment relates to the tender offer by Atlas Merger Subsidiary, Inc. a Delaware corporation (&ldquo;Purchaser&rdquo;) and a
wholly owned subsidiary of Salient Federal Solutions, Inc., a Delaware corporation (&ldquo;Parent&rdquo;) to purchase all of
the outstanding shares of common stock, par value $0.0001 per share (the &ldquo;Shares&rdquo;), of the Company, at a purchase
price of $3.20 per Share net to the seller in cash, without interest and less any required withholding taxes, upon the terms
and subject to the conditions set forth in the Offer to Purchase, dated February&nbsp;28, 2012 (the &ldquo;Offer to
Purchase&rdquo;) and in the related letter of transmittal (the &ldquo;Letter of Transmittal&rdquo; and together with
the Offer to Purchase the &ldquo;Offer&rdquo;). The Offer is described in a Tender Offer Statement on
Schedule TO, originally filed by Purchaser with the SEC on February 28, 2012 and amended on March 1, 2012. The Offer to
Purchase and the Letter of Transmittal are filed as Exhibits (a)(1) and (a)(2) to the Schedule 14D-9, respectively, and are
incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; text-indent: 24.5pt; background-color: white">Except as otherwise
set forth below, the information set forth in the Schedule 14D-9 remains unchanged and is incorporated herein by reference to the
extent relevant to the items in this Amendment. Capitalized terms used but not defined herein have the meanings ascribed to them
in the Schedule 14D-9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; font-size: 10pt; font-weight: bold"><B>ITEM&nbsp;9.</B></TD>
    <TD STYLE="font-size: 10pt; font-weight: bold"><B><I>EXHIBITS</I>.</B></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4.5pt 0 0; background-color: white">Item&nbsp;9 of the Schedule 14D-9
is hereby amended and supplemented by inserting the following exhibit thereto:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4.5pt 0 0; background-color: white">&ldquo;(a)(9)&#9;Salient-ATSC Transition
Help Q&amp;As, dated March 6, 2012&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 12pt">After due inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this Statement is true, complete and correct.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ATS Corporation</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">By:&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border-bottom: Black 1pt solid">/s/ Pamela A Little</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Name:&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Pamela A. Little</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Title:&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Co-Chief Executive Officer and</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Financial Officer</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dated: March 6, 2012</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: left; width: 50%"><IMG SRC="logo.jpg" ALT=""><BR>&nbsp;<BR>Salient-ATSC Transition Help Q&amp;As</TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white"><B>POSTED 6 MARCH 2012</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Will any Floating Holiday balances will be transferred?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0">Any unused floating holidays will be credited to your holiday
balance at the time payroll is transferred. You must use all floating holidays prior to the end of the calendar year. Any floating
holidays that are not used by the end of the calendar year are forfeited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"><B>I have a small amount of stock in ATSC, and would like to
get more information concerning when and how the stock will be purchased. At what amount will the stock be purchased?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">A tender offer package should have been sent to
your home address by D.F. King, Salient&rsquo;s Information Agent for the transaction (via regular mail last week). That
package outlines the process for Salient&rsquo;s purchase of the shares of ATSC stock that you own. If your shares are in a
brokerage account, you will receive that information via your broker and you will need to process the transaction with your
brokerage firm. If your paper certificates for your shares are still in your possession or are in the safe at headquarters,
you will need to complete the paperwork in the package you receive (the Letter of Transmittal and any other documents
required by the Letter of Transmittal), attach that paperwork to the original paper certificates, and surrender those shares
to the buyer per the instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><FONT STYLE="color: black">For those with paper certificates
either in your possession or in the safe, ATSC can help you complete the paperwork and submit the certificates and paperwork together
on your behalf as described in the documentation you received. Please contact Joann O&rsquo;Connell (</FONT><FONT STYLE="color: blue">joconnell@atsc.com</FONT><FONT STYLE="color: black">
or 571-766-2790). In any case, you will need to send in the information by March 26, 2012.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0">Pursuant to the merger agreement executed on February 21, 2012,
shareholders will receive $3.20 per share for their ATS stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"><B>Will the old ATSC employees be given the opportunity to
keep their 401(k) plans with T Rowe Price? Or, will it be a must to rollover their 401(k) plans to the new employer 401(k) plan?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">The ATSC 401(k) will be terminated
prior to the closing of the acquisition. All accounts must be distributed out of the plan as part of the closing of the plan. To
preserve the tax benefits of the 401(k), you will be given an option to roll over your money into a qualified IRA with another
firm of your choosing including T Rowe Price or you may roll it into Salient&rsquo;s 401(k). Salient&rsquo;s 401(k) provider, Diversified,
will be traveling to ATSC sites to discuss our plan and to help make rolling the money into the Salient plan easier for you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: left; width: 50%"><BR><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: left; width: 50%"><IMG SRC="logo.jpg" ALT=""><BR>&nbsp;<BR>Salient-ATSC Transition Help Q&amp;As</TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white"><B>Currently, ATSC is using
T-Rowe Price and I have been very happy with the selection of the mutual funds I have made for my account. I would like to know
who manages Salient&rsquo;s 401k accounts and where I could find what mutual funds they offer?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">Salient&rsquo;s seasoned executive
team has negotiated benefit provider contracts with best in class providers who typically deliver services to company many times
our size. This includes our contract with our 401(k) provider, Diversified Investment Advisors. Typically delivering services in
the jumbo employer marketplace, Salient was able to cast the vision and sell a true partnership to Diversified. Diversified has
been honored to receive widespread industry recognition for excellence in retirement plan services (<FONT STYLE="color: windowtext">www.divinvest.com</FONT>).
Our mutual funds line up is truly best in class for a company sponsored 401(k) plan. Our mutual funds are assessed and measured
each quarter by an independent financial advisor, Barney &amp; Barney. You will be receiving a detailed package of information
that you can review with your financial advisor that will include the funds line up. Additionally, Diversified will be conducting
employee meetings soon after the closing of the acquisition. As with all financial decisions, we recommend that you weigh all the
pros and cons and make the decision that is best for you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"><B>What is the vesting schedule for the 401K? Also, can I remove
all my money during the transition?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">Salient&rsquo;s vesting schedule
is graded with 33% vesting each service year for all new contributions made in the plan. Your ATSC service is grandfathered for
purposes of vesting. If you have been with ATSC for 3 or more years, you will be 100% vested in Salient&rsquo;s matching contributions.
If you have been with ATSC less than three years, your matching contributions will be subject to the graded schedule. If you roll
money into the plan, the money that is rolled over is 100% vested and will always be your money. All ATSC 401(k) must be distributed
out of the plan. To preserve the tax favored status of the distribution, the funds may be rolled into a special IRA or into Salient&rsquo;s
401(k). We will be hosting a number of meetings at various ATSC offices to help employees fully understand their options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"><B>I elected to have both a health care FSA and Dependent Care
FSA in 2012 through ATSC. What will happen to my accounts?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">Your health care FSA will be terminated
at the same time your benefits are terminated (which we expect to be on May 31, 2012). You will have a grace period to file claims
for services received prior to the termination date. Flexible spending accounts have a use or lose feature. Any money left in your
ATSC health care flexible spending account after the claims filing termination period will be forfeited. During your special open
enrollment period with Salient, you will have several pretax savings accounts that you can choose to participate in for the remainder
of 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">Your dependent care elections will
remain in place but the vendor will be changed coincident with the move to Salient benefits. We will automatically set your dependent
care FSA election to the same level you chose for 2012.</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: left; width: 50%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: left; width: 50%"><IMG SRC="logo.jpg" ALT=""><BR>&nbsp;<BR>Salient-ATSC Transition Help Q&amp;As</TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"><B>Why not continue the ATSC Kaiser &quot;option&quot; in
Salient? ATSC already has an established relationship with Kaiser. Many, if not most, companies in the Federal IT Contractor market-space
offer both a PPO and HMO option. Kaiser is less expensive for both the employee and Salient, and it arguably offers superior &quot;health-maintenance&quot;
than more conventional health insurance. Finally, keeping the Kaiser option alive will eliminate the need for many current ATSC
employees to scramble for new doctors, which could result in a smoother transition for Salient as well.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">We understand that participation
in an HMO is convenient. Salient&rsquo;s health and wellness philosophy is built upon engagement. We believe that consumers of
healthcare should be knowledgeable about the cost and quality of their care. Our consumer-based model does not include an HMO.
As we approach the open enrollment period, we will be providing a number of opportunities to learn more about our healthcare coverage
and pricing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">Our healthcare philosophy is part
of our total rewards strategy which is designed to bring value to our clients, to our company, and to our employees. We have designed
our programs with great care and deliberation, and believe that our strategy will allow us to build a top performing mid-tier federal
services company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">The ATSC Kaiser total premium, which
includes both the employer&rsquo;s and employee&rsquo;s share, is similar to Salient medical premium. It is important to note that
market trend for HMOs and PPOs are escalating far more quickly than that for a consumer-based medical plan. The future escalations
will cause the Kaiser premium to quickly outpace the premium for Salient&rsquo;s consumer-based plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"><B>Currently, we have Kaiser Permanente. This plan is cost
effective for us as well as very convenient. To choose Cigna to provide health care coverage for those of us who currently have
Kaiser would be more expensive for both Salient and us individually. As I am sure there are multiple ATSC employees who participate
in the Kaiser Permanente plan, is it possible to keep this health care option under Salient? </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"><B>Also, if keeping Kaiser will not be considered, can you
provide the health benefits summary that includes employee cost and coverage? This will allow Kaiser holders to weigh their options.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">For first part of question please
see previous question. As we approach the open enrollment period, we will be providing a number of opportunities to learn more
about our healthcare coverage and pricing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white">***</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: left; width: 50%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: left; width: 50%"><IMG SRC="logo.jpg" ALT=""><BR>&nbsp;<BR>Salient-ATSC Transition Help Q&amp;As</TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white">This communication is neither
an offer to purchase nor solicitation of an offer to sell securities. A subsidiary of Salient has filed a tender offer
statement on Schedule TO with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;), and ATSC has filed a
solicitation/recommendation statement on Schedule 14D-9, with respect to the offer. The tender offer statement (including an
offer to purchase, a related letter of transmittal and other offer documents) and the solicitation/recommendation statement
contain important information that should be read carefully before any decision is made with respect to the tender offer.
Those materials have been made available to ATSC&rsquo;s stockholders at no expense to them. In addition, all of those
materials (and all other offer documents filed with the SEC) are available at no charge on the SEC&rsquo;s website: <FONT STYLE="color: blue">www.sec.gov</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: left; width: 50%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D
M``#_X0,I:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B`\
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835`@0V]R92`U+C`M8S`V,"`V,2XQ,S0W-S<L(#(P,3`O,#(O,3(M
M,3<Z,S(Z,#`@("`@("`@("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<#TB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87`O,2XP+R(@>&UL;G,Z>&UP34T](FAT='`Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]M;2\B('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C`O<U1Y<&4O4F5S;W5R8V52968C(B!X;7`Z0W)E
M871O<E1O;VP](D%D;V)E(%!H;W1O<VAO<"!#4S4@5VEN9&]W<R(@>&UP34TZ
M26YS=&%N8V5)1#TB>&UP+FEI9#I&.$$V1#4V.#8W0D(Q,44Q0C=%-$$U-#<V
M-3E".30Q0B(@>&UP34TZ1&]C=6UE;G1)1#TB>&UP+F1I9#I&.$$V1#4V.38W
M0D(Q,44Q0C=%-$$U-#<V-3E".30Q0B(^(#QX;7!-33I$97)I=F5D1G)O;2!S
M=%)E9CII;G-T86YC94E$/2)X;7`N:6ED.D8X039$-38V-C="0C$Q13%"-T4T
M034T-S8U.4(Y-#%"(B!S=%)E9CID;V-U;65N=$E$/2)X;7`N9&ED.D8X039$
M-38W-C="0C$Q13%"-T4T034T-S8U.4(Y-#%"(B\^(#PO<F1F.D1E<V-R:7!T
M:6]N/B`\+W)D9CI21$8^(#PO>#IX;7!M971A/B`\/WAP86-K970@96YD/2)R
M(C\^_^X`#D%D;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!
M`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@`5@#Z`P$1``(1`0,1`?_$`-0``0`"
M`@(#`0`````````````)"@<(`P8$!0L"`0$``@("`P$`````````````!P@!
M!@4)`@,$"A````8"`0,"`@,)#08'`````0(#!`4&!P@`$1()(1,4"C$B%4$C
M5197MQB8&E&2TC,DU9;6%S=WUSEAM7:V>!EQLG1U-D8X$0`!`@4#`00#!@X/
M!P4````!`@,`$00%!B$2!S%!41,(87$B@9$R4A07T>%"LM(CD[-TE!46-QBA
ML<%B<C-#<]-4U#5U-@GP@I)38Z,D@S1$)47_V@`,`P$``A$#$0`_`+_'$(<0
MAQ"-4=H=WM7--JT%EV&R]5J&1P"I8F`</4WMMGW"295C,X*LLS*RL@Y,D;N`
M`3*40]>[FU8QA.49C4_)<=HW:A0^$H"2$#O4L^R![L<)>LCLF/,>/=ZAME/8
M"?:5VZ)&I]Z-(-"/-+KIY`L]9%P5CBJV^ER%7KR%JHLO>%F#-SE"$06%O8EX
MNO(E,]@W-<441,LBX54.HDN4X=``0YN^?<+Y'Q]8::^W-UEYMYPH=2U,AA75
M`4OHH+$Y$`2(E&KXIR19<NNC]LH$N(6TD*05R!<3]40D=-IZ@DS&L3&\AZ)#
MAQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'
M$(<0AQ"'$(<0CIU_R#1\5T^>O^1[7!4FEUB/<2D]9;)(MXN)C&35(RJJJ[IR
M<A1.8I!`B9>Y54X@0A3&$`'[*"@K;I6-T%N:<?K75!*$(!4I1/8`/V3T`U.D
M?/555-14ZZNL<2U3($U*40``.\F*?OD.^9/G)IS.8LT"C@A81,RT>^V(MD8D
MYEY4.U1)9;&]0D$E6$8T`Y2F1D91-V=PD<>UHV4*!N6_X[\M;+2$77/U;WC(
MBD;5()]#S@U)[T(*9'ZM0TBN^8\UK*EV_$4@)!(-0L3GU_BD'30]%+G/XHZQ
M6"8QN?ML\INUX]CE/8?,%E<I$D7J9+!D"V.5'"@@W3DY1<SXT5'D.;HD#A9N
MT1+Z%[2ATY:!QW'<0M02XJDMUG:&@]AI`EUDD2W'OD"H]LX@Q#5]R6O*D"HK
M;@X=3[2U>^=`.LAH!V1.9I/XP=I]+\M8EW*V7S+A_2*O8XFFUE^RLASRUNR3
M98<PG9SE3<8XJ#UL+QE-,5!14!.37[#]#&2'V_6KO,_F-XDIL7K;%6.*JVGV
MRG?HTV%#X+C:EA2U*21,2:]W6+0\%>6/FO.<LI5X;;GWZ]#FJ&D%S0C5#JYH
M:;"@==[G=('LO3XNR=2,S8_JN4,;SK6RTBZ1:<Q7IIGW>R]9G55;J=2'`#I+
MMG2"B*I#`!DU4S%'U#E*;=<*.[4+5QMZPY1O)W(4.A'TCH1V$2BPF68I?\'R
M2LQ+**==)?Z%XMO-*ZI5($=-"%)(4DC0I((ZQWWGVQKL.(0XA#B$.(0XA#B$
M.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(1CS+.5*+@_
M&MVRYDR=;5JAX]KTC9[1-N^HI,8J,0,LL8I"@)UEU1`$TDR@)E%#%*'J/.0M
M5KKKW<F+3;6R[7U#@0A(ZE2C(?1)[!K'RUU;36ZD<KJQ012M(*E*/8!_MIZ8
M^='Y`_(ULSY6<WM,>4Z'M9L4K6I:,PCKU36CV0DITHKE1CIZX,8TISV2UR*2
M)72H*E%E$D-[9!$J1W*G8MQ]QQC'%%C-SKUL_E8-;JFK<("4:3*&R?@('P1+
MVG#KVA(IQE^:7WD"Z"W4"'/R<7"&6$`DKET4Y+J3UU]E$Y=DXE/U,^7CI&/:
M$78'R>Y8CL;5**;DF7>):[86,<FQ;D)\4W97N]J`LW4E'!DA2/#Q"3T[H#]B
M3D%A[.0KR5YIZ.TM/-8@&VZ1L$*K*C1/;/PFR03^]4J2B=/#,3%Q=Y:K]F-V
MIK6Y35-POM2L!NBI4E:CJ/XQ0&B1/[8=$(3[2G``2.W9D\KF(=?:\^P=XM\&
M4C"=*9D<Q+C,3FLMT[%,-P6'O5K42[^(EED%3`"K=_-NUG!1*'5D7TZ=8W)G
MF5R3**Q:;=4/5#I)G4ODGT399T2D$=%$)/[R.]ORZ_Z:6-8U2,7KE[P_&DE2
M;51G:VGM`JZH>TXH=%M-33W5!B%"W77*>>+X68NMCN^7<D6%VJ=J:27D[79)
M!XX'[ZE!P[5-PHB*IA_B&#=,@_<)RM%5676_5WB5CC]7<%G2<UJ)_>I$Y>I(
M$=H-FL6(\>X\:*Q4M!9<7ID#=L"*=A"1T+KBB`9?&=63Z8MZ^#:J;<XKQ#<,
M7YXQ-::5BE*0;V[$<Q;E8^,F6;J<`Y;353U1P^+9XB-!9!!\@#ED@4KEPZZB
M)C]`M9PU2Y3;+0[;;Y2N,VT*#C"EE(4-_P`-&R>](!`4-R1JI4=+7G^O'#.7
M9I199Q[>:2OS`MFFN+5,%K:4EK^(J!4)1X#BY%;2]CJB4(:D)"9G<Y-$=>\=
M'R3DJB8?HEHR9DVT15,HE+AWD]9K+-+_``\?%1;%(RSA=42E.JJ?M+T(DF4Z
MJIQ`A"F,(`/VVZW5UWKFK;;6EO5[RPE"$B94HZ`#Z)T'4Z1\U75TU!3+K:Q:
M6Z5I)4I2C(`#J3$&,M\REXYH^2>L61LU3S1JX41;S,9CYFC'R21#"!';-*7L
M49)IH+!ZE!=NBH`#]8@#Z<G)KRV<D.-I6M-&VLC5*GM1Z#M2I,_42/3$8+YG
MPA*RE+CZD@]0V9'TB<C[X!CU_P"TO>/#\%9Y_H'!?UQY[/U:>1N^A^ZG["/'
MYZ<*^/4?<_IQ^3?,P>.\A3'&*SST*43#TH4%UZ%#J/\`]Q_<#F1Y:>1CI.A^
M['[",?/3A/QZC[G].)J,H;&X=PGA)_L+ERYQ^/\`%<578ZR2%@G@5!1%K+((
M*QK!M',2/7\I.2"CDB+=DT37<N%C`1,AAY"UKQV\7N])Q^T,JJ+JMPH"$=I2
M3,DF02D2)*E$`#4D1)-==[?;+<J[7!U+-"E`45*[`>@D)DD]``"2=`(A@=?,
ML^.Q!RX019YS>I(KK))/&]!B2-W:::AB$=(%=6MNY*BX*4#E!1--0"B'<4H]
M0"9T^6KD=20H_(4DCH7C,>@R01,>@D>F(X/-&$@D!=01/KX9U]\QP?M+WCP_
M!6>?Z!P7]<>9_5IY&[Z'[J?L(Q\].%?'J/N?TXSGKOY[/'UL5DR!Q1$6^Y8\
MLUK>MXJKN,G5A.!@9J9=J%2:1!)R.DYIA&NW2A@*F9\9JB8X@4#]P@`\'D7`
MW(6.6QR[/L,U%*RDJ7X*]ZDI'56TA)(';M"B!K*4<G9^5<.O-<BW,/K;J7#)
M'B(*0I1Z#=J`3V3(F=!K&TF]WDAU_P#'E%8XF<\-;RZ991EIN&K8TB#83:A7
M<#'H23T9`KV8B001%NX+V&*)^XWIT#Z>:M@O'&0<AO5+%@+`<I4)4OQ%%.BR
M0)229Z@SCGLGS"SXBRT_=RX&WE$)V)W:I`)GJ.\1D;2[=+$6]N(W.:,+-[4V
MJ#6U2E0.2WQ;6(E32L0TCGCLQ6C.1DTA:^U)I@4PJ`(B`^@=`$>.S/#+O@MW
M%EO9:-86DN?:U%2=JB0-2!KH>R/LQW(K=D]N%TM96:4K*1N&TS3*>GNQMSS4
MHYV-#][/(A@;QYUB@6S.[6[NHK)%DD*M`?B5",9MP23C8A>:<"_3>RT25!N+
M-N8"F*8XB?H'3[O-ZP7CR_<A5511V$L!ZF:"U^(HI&TJ"1*253,S&L9/EMIQ
M*G;JKN7`TZLI3M3NU`GKJ(_6J?D.P/N)@7(.Q6)VMW1H6-GUCC[`E9X1C%S:
MB]7@T9^2%@Q;2\@BN062P`F)E2=Q^H=`#UYC*N/K]A]^8QV[EG\H5"4%.Q14
MF2U;4S.T2UZZ&,V+++5D-I<O-N+AHFBH$J3(^P)JD)Q&DC\S'X[ET4ER16>@
M(LDFJ4#4*"`P%4*!R@(!<1`!Z#R2SY:.1@2)T.G_`%C]A&E_/3A0T*JB?\W]
M..7]I>\>'X*SS_0."_KCS'ZM/(W?0_=3]A#YZ<*^/4?<_IQ^TOF6O'DLLB@2
M+SQWKK(H$ZT."`.]=4J1.H_CCZ%[CAU_V<P?+5R*`5$T,@)_QI[/]R`YIPHF
M6^HF?^G].);]E=RM?=1L.HYPSS=T*737Y&*<(W.U<R5BL<I)-BN6<+`P,<FY
M?2,BHF<.\2A["`#W*J$)];D28UAV09=>/R'8&"_6B>[4!"$@R*E*5()'KU/0
M`F)`O60VG'K<;I=G0U2Z2T)*B>B4I$R2?1[L8RT<\C>L_D$K]NF,#6"5+*4:
M32862F6]BVA+@Q9.T2*1U@+%(/Y!-Q`22ONHIN$U3=JR!RJ%((D[^4SCCK)N
M/ZAEB_M)#;Z)H<;)4V2#JC=(>VG0D$="")ZR^'&,PL>6LN/6=PJ+2I*2H;5B
M8T.WXIU`/>#&^/-$C:(A`P]Y_-',WYNQ[@*FQV94[QDO(<=C*NJ2U,AVD,2Q
MR<FI$MC/WJ5I<K-X\'28]RA4CF`OKVC]')NO'`6=6.R5%_K31_(::G+R]KI*
MMB4[C(;!,R[)Q&ENY7Q.Z7)JU4JGS5O.AM,T2&XG:)F?2<9;W-\R>I>BV8"X
M2S2QRBO<#UJ*M15*C5XN7B1C)?W`:A\6[L,8L#@!2'N+[70/W1YQ&&<.9=G5
MH-ZLAIOD8=4W]L<*5;D]=`DZ:]\<ADG(F.XK7BVW4NBI+86-J-PVDD=9^B-3
M?VE[QX?@K//]`X+^N/-L_5IY&[Z'[J?L(X#YZ<*^/4?<_IP_:7O'A^"L\_T#
M@OZX\?JT\C=]#]U/V$/GIPKX]1]S^G&?=7_.AICMMG"FX`Q;'9=2O-Y-(EAE
M+)48B-AB?9C0SQR+QZWLSY9$/9+]7M2-U'G`91P;FN(V-[(+J:3Y`QMW;'"I
M7M&0D-@[?3'+V+D[&,BN;=IMJGC5N`RW(D-!,ZS[HF9Y#<2'%6WYI?+]LJ6M
M.O\`B*'75:5;+N49Q_=3)]Q!D&N.X1G-PT9[A#%,9$\F^!19,W4BA2``@/IR
MT?E:L])69/7W=X3JJ.E2&_07E%*E>N0D#Z8@[G2Y5%+C]-0-&3-2\K?Z0V`0
M/42J?K`CT'C#Q#J]XM]`8#R"9J9,K+GC.,`H[KAR?"/IQM$2;MW^*F-,=D4,
M<C->9:1Z<A+O`[3@)P34$"-R@>//-+S6JEN55;:QU36.6YWPT,IT545`&I(^
MJ()*4#X*4@J[8F_R?^6N_<JWFBLF,-(5?*YOQJBJ6"6J.EF)K4KL2`1H/:6L
M[1TB)+8_:S:OR39F8,7K*R6'[3E%66+\#T)&2DX2N-U^@@FUC&A3*3<VJ@@"
MCV07()C`F'3M(F`\ZM<@R?*.1+LEHI<6E2I,TS4RE`/H'PE?&6?VA'Z2^+^(
M.(/*Y@SE0PY2TWA,A5?=JLH;=>([5+5HTT"9-,H,ANUFI1B5[4GY?:U6)&+M
M^W]V4I[!8K=W_9-CUX@YL)DC=1596:XI^\RC51+T$OV<94Y>O:<0$!#DG8MP
M2^\E-7ECQ;09'P&C[7J6YT!_@3],4]YE_P!2&T6Q;MEX5H!6U*2I/Y0K$E+,
M^Q;%,9*6.P^,$@]4@@SBQ)@#3;6C6&))%X7Q'4ZDL9-`KZ>+'(O[/+JMRE(1
MW+6!Z5:1>.S`4.XXG#J(?1R>[)BN/XZUX5GI6F>]0`*B>\J.I/NQUG\C\X<J
M<L5IJ\ZO596(F=K.\H8;!,]K;*9(2GN$C&SG-AB*(<0B!#YDA\]:>,BVH-';
MALC)9>PVQD$D%3)$?,C7!LN9FZ`HA[S8ZR!#"0?JB)0Z\GGRWH0OD]@K`)32
M5!$^P^'*8[CJ=8BSF12DX,\$D@%YH'TC=T,5MO"QI)HYN)_;X&Y$^\@ST4])
M&BF;9:6Q@1=*8),_;?ND1<M?M<Q5&J':83_>>HAT'NZA9/FS.,XPY5O&'("P
M^'/%FQXVJ2G;W[="?7[D0QQ;BN,9&S6+R`D.-+0$?;`C0@ST/77MB=W_`+(W
M@[_*%)_K8O?YYY`_SW\W?\A/XB/L8ECYL.-_C_\`?3]".T5;P&>&R^NEXRF3
M%TMCY)+O795W9N;F':2)OJ^X=NPDEU2D]?IZ=.?+5<^\QT*0Y6)9:03H5T:4
MCWR!'N9XHX^?5M8W+4.P.@_L2C&?S-Z*E2T:P'2X-Z_:UQ+,<!#K1PNU%$Y!
ME7JTX&'))"8>KU1BJW(H0Q_4%0[OIYR?EC(J\\KJQ]*34?(EJ!ET*UC=+NG.
M7JCC^;MU/B###1(:^4H3*?4`:`]\1(^&/0'Q\;?X;R[;=P[*]@KE4\I(UJJ(
MM\T.,9IKU92H5^5,J,4B[:!('+,/G`"Y$3>G0G0.SDN<T\@\@8?>Z.CP]M*Z
M-ZDWKG3^-)SQ%I^%(R]D)T]WMB/>+\0Q3(K34U-_5*I;J=B?M@1[&Q!Z'TDZ
M^YV1,E_V1O!W^4*3_6Q>_P`\\AKY[^;O^0G\1'V,29\V'&_Q_P#OI^A%13R#
MXBQ!@'<G-.)=?G[IWB>D6"-9TN04M2MN=&1-'M'+A4MI]PRSXY'QC=I^\3)]
M`#N'IUY;SCN\7C(<+HKOD"0+L^A1<&SPQU('L=FGOQ7/-[9;K-E%1;[03\A;
M*=IW;C,B9]H>GWHL8?,W.7#S7[Q\.W:RCETYE+:NX<+&$ZJZZN.X`ZJJIQ]3
M**',(B/W1'E<O+$E*,AR!*0`D-M@#_UEQ-'.1*K):R=25K^L;C?[Y:#_`$\I
M?_'F]_[AIW-`\RWZ11^`M?MKC;.%O\E(_"'/W(L,<KW$M15&^:N_N,U(_P`:
M[=^;N5Y:SRJ?W_=OP%'WY,0/SS_<E#^$J^LCG\!/^D[MW_Q3F;\V##GAS]^E
MFU?S5-]^,>WB7]'=7_#J/K(J]^,7">#MB-N<,8AV.?+QN(+4QG2V=XVMIZ,L
MBI'U5Z_B>VS)F(=@4TF@F`E`Q?=#ZG4.O7EH^4;Y?,<Q"LO&.)"KNTI&P%OQ
M="L!7L=NGO=8@K!+3:[WE#-NO)(H%I63[6S4#37U]G;%MO\`[(W@[_*%)_K8
MO?YYY4?Y[^;O^0G\1'V,6&^;#C?X_P#WT_0C)M2^7D\3%RC6UDI37)]IA@>*
M$;S%>V&M$Q&'>1SD"KHD>L'J[<ZK9PGVJ%`W4I@Z#T'G&U7F&Y9HW#3UBJ9I
MZ6J5TJ$F1&FA$]1'U-<18&^CQ&$.K;.DTNS'N$#KZM1$<'S3YEXQ72VIM7CS
M\7XF/ORC*,5<'4;)N4FL9'`],0W\8\,R:)IF4'J82E#DC^58)<-ZJE`>.HM3
M,M9349>J9)E&D\]E2&K8RDGP@7=.SHD3]>D5M=6]E,X:29HQ[L/B5U(0,[']
M[E-E()ND:UDBE+NU(^PUF71'L0EH&3,S42]PO<+5ZB14@@HET&RF58U8LXLM
M1CMV"7&3I,2*V70)H6GM2I,P9?5))!T,0ICU\NN*7-F]404DD'0S"76YR4GN
M()$I]A'81'TLM&=U<3[Y8"K.<L6._A_CDR1USIKQP@I/T&WMTBC*5J;21.8`
M404'N06#ZCA$2G+]T`ZTLXPN[8)?W;%=1,I,VW`#L=;/P5I/<>T=0=#%V<8R
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M#T,/+&<(<N9EGF7/6;(7*=5"BWN/`(92V=Z7&4CVDZRDM6G;$,\I8!CF+8ZW
M<;2AQ-2JK0V2I6X;5(<4=)#M2(PEX(_&/JIY"*9LI.;'PUYE)'%MTQ]!U,]/
MOTY3$48ZRUR:DY(CY"'.0K]8SM@02**=1(7ZH>G7KS?/')V5<?5MM8QQ;"&Z
MIEU3GB-)<F4+2E,BKIH3H(XWBC";#E=)6/7A#BG&5MA.U6W1063I(]PBS+K7
MX/="]3\T5#/>'ZYE)CD.CFD#0+F?RQ:+%$IC)M#,G7Q<._5,T=@9`X]H']"C
MZ_2`<K)DO-^>9997K!>'*55N?EN"6$(5[)F)*&HUB<++QMB]@N*+I;FW4U;<
MY$KF-00>P=AZ3E.1[!$O?(BC?HB]\LGCMC?(SK0KCF-EF%8RS0Y92ZX@M,F@
M*\<TL9&AFTA7I?MZJH0=M8E!JZ52Z*I`!#E'H!@&3^)^1'>.<F%R6E3MJ?1X
M=0@&1*)S"T]ZFS[20=#J(TK.\19S"R&AF$UK9WM*/QI?!)[$JTGZ0"00"#28
MRC+;*52"H6J^Q<O)"]U60L..XBG1C=2T(U%%Y99*PS"\>V@4RNKD\%*2`Z2Y
M`%PY8(-T"&*FFF!*A>9._'FGS$O6#`T@T=354]-2A9\-+CSC39=><"C)N2BH
M+[DM3ZF.^/R'83CWEI\FK7)&<*";@[;ZJZ7)Y("G!3L./)IJ9M0GN'A)1X:9
MD>.^J6ABQ#H9O?XC]*L;Q\/29',DQDFP1[92^Y$G==LC!<[!(*%25<QJ8)P*
MZL-7VKI+JWCD#BD0"@<PG4$3C:'$?*?EN#T1I*1BB<KB/MK_`,J8)<5VR45`
MAL'X*=`.T3G'4?S[YWG_`#!9$;G>ZJHI<8:6?D=O0VZ&6$:A*EI`*7*@I/VQ
MTS)F0DA$A$B;+S$X>N:9QPOK5NSF@_0JC5Q4]<+9&Q#]`R(N0<-):R'BB*I&
M:E,H`@GZ@7IZ#Z<V=SB"[T1_^YN5DHCVARL;*DGI(I1NUGIUB!4Y_05`G;J*
MZ5*93"FZ96U0ZS!44]GHC&MG\S%CQ\FO,Y+\;N]%&I2!G?N6V0QZT?HE1;=I
M@6/%1BSE^0#I'`Q@Z=2=>@]><C3<.T]P(9MN26%^M,OM8>(.O9N(`^C'RO<@
MN4OVRLL]V:IA/VRSI[H!G]",Z:J>9+0S;JU-,>4+*;JFY.?N?@6&.,M0;O'E
MKE)`B(++,HAI,&!"2<)E'T(10%#^@%*(^G.%RKAW/,1I3<+A2!ZV)$R\PH.M
MI$Y344Z@>DB0[3'(V/D#%[_4?(Z.HV5TY>&X-BB?1J0?<,S$I?(NC=8U+W?U
M"H.\^MM^URR(]D(:*MR3!_#62)[#2=5ML`\3E*S9&:*W\G=GBI-$ASH*@*2Z
M0F3.`E,/-LPC+KA@V24^1VT)6\R2%(5\%QM0VK0>T;@>HU!D1TC@LDL%'DUG
M=L];,,N`2(ZI4#-*AZCV=HF(J&S_`,KAMVPEG;:N[`84GH@A_P"1RCB&M4(Y
M<)#ZE!Q'F>//96(`]#=%#%$P"(#TY;RG\TN)N-!53;JU#W:D*;4/<,AI[D5Z
M=X&O25D,5M.IOL)2H'W1'I_V7W=;\M&#OWEH_A\]WZT6&?U&N]]OZ$>KYB,@
M_KE-[RXB%V>U_P`Z>,C:M+'#G([=EF'',54L@PE\QM(24<6-/8$7;N+.Q<J+
M`\2=(%9&*L41[3`;M$.@B')?Q?(+%RAB9N(I2;/4K<94T\$JGL(!G(2D9Z'J
M.L1S?[/=L"R!-,FH'Y092EQ+C9(EN$^W7U]A&D62_/ID69R[XMM&,HV,J19_
M(-BH-OF00(0B/VG/8Y"1>BF1,"D(0SA<P@```!]SE:>`+>S:>4[W;*>?@4[3
MS:?X*79#]@1./+U4Y6X%05CO\:ZXTH^M29F(,O'YXC,^>1:@WO(F([[CVI1%
M`N:5(E&EQ^U3/7<FK!1=@!RT+''`H-`:2I"]3!U[RCR=^0N7K#QS<:>VW:GJ
M'G:ACQ4EO;()WJ1([NV:3[D1)AO'-SS.B>KJ%]IIMEWPR%A1).U*IB79)0C?
MS]E]W6_+1@[]Y:/X?(__`%HL,_J-=[[?T(W#YB,@_KE-[RX@IVFUUMNIN?LB
M:]7J8AI^UXVE6L9+3%?!P$0^4=-47J2K,KHQG!2^TL`"!QZ@/IR=L4R2DR['
MJ?(J%"VZ6I22E*Y;A(R,Y:1$^1V.HQN\O6:J6EQ]DB:DSD9B8E/6+/'S,O\`
M^=O'C_Z^U?FXK_*P>63_`#'D/\!O[\N)XYQ_N.U?PE_6-Q()\M!_IY2_^/-[
M_P!PT[D?>9;](H_`6OVUQMO"W^2D?A#G[D6&.5[B6HJC?-7?W&:D?XUV[\W<
MKRUGE4_O^[?@*/OR8@?GG^Y*'\)5]9'/X"?])W;O_BG,WYL&'/#G[]+-J_FJ
M;[\8]O$OZ.ZO^'4?614CTTUANFX^;L;Z[X]FH*O6R^,WOV;+V3XD8=H$+!K2
M[H70-#$<&$[=H8I`*/43"'+=9IE-%AEBJ,BN#;CM*PH32B6X[E;1*>G4Q7C&
ML?J<HO2+-2+0V\X%'<J<AMU/36)T/V7W=;\M&#OWEH_A\@K]:+#/ZC7>^W]"
M)3^8C(/ZY3>\N+27B9TWR'H?IO6]><H6"N6:V0]\R3:'$K5?C/LA1E<;0[FX
M]%/X[^4>^@W7`JG7T[OHY5KEC,K?GF8NY%;&W&J5;#*`E<MTVT!)Z:2)Z1/&
M#8[4XOC[=HJEI6\A:B2F<M9=_P#MZ^L5_P#YK#_Y/I__`.VY"_\`.TY8#RI?
MQ-X];/[L1!S]_P#F^MW]I,=GTP\:U"\BOA/QG73DC*WG"CVW*DKA[(ZK4GQ$
M;*&F>YQ5IMR0GQ+BHV,R1".4NH@BJ1-<H"*8E-\F9\E7#CGFZKJD[G+(^VPF
MH9GHI.P26D=`XC4I/:"4]#'U8WA5%F?%U+3.21<6BZ679:I5O/LGO0K3</4>
MHB$#2?;S8KP_;@V.,N-9L$<SBYQ.C[&X1D3`W+9()F[*8DK$%<@=HC/L&X@]
MA91,/OJ)_:$QFZZR9IRS;$,=YBPYIZA=;4XI'BT=2-=BB-4JEKL)]EQ!Z'66
MY((BO%\AO'&N2N,5J%AH*"*AGL4GL6F>FX=4*'43$Y$QB/QK.B/O)GI=()D,
MFE([:X_D4DSB`G32?VU5XFF<0Z`)TR+``B'H(ASF>2TEOC*]-G4IM#H]YN7[
MD<7A"@O-[<L=#7MGWW`8^I!SJVB]D5QOF@O]/3'/_5KC/\VN9^6/\KWZ0ZG_
M``A[[]31#'.G^3V?\0;^]/1J_P#*B_W;;L_XEX>_Y-M'-G\U_P#>=D_!JC[X
MB.%X#_\`87'^=9_:<BVSRI,6!AQ"'$(J(^2+`67]*/(!7M]Z/2IB[8E>WRO9
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MLBHXF$RJIE#Z3%$0YS3MZL["0IZKID)(F"IU`GZIJUB-*7COD"M<+5'8KPZZ
ME4B$452H@GH"`V9'T&-?;CY(]#Z"HY2M6U.'F"C1-95<K:T(S`E(@H*2HE^Q
M$Y$%1*H`AT)W&'[@"'.%JL\PVC)%1<J0$=S@5];.?N1)%D\KWF%R)*5VC$+V
MXE9`&Y@M:D3'\:42T[3(=\5-_/A->/O,L%B7:73W)F.GN:%KLK7[V.+R2%?E
MK&Q]@TM!WI^W2B8LK6RU*7CCE+)@*3Y07:7<90$4Q3N7Y2^5Z3,*^NPRFKTW
M"V-TGC)0HJ7X0"MBT26)AMS</85I[)VC54ZL^;+RV<G<.6RCS/.,>K+&^Y7)
MI_%6&TAQQ:%.(U0M6Y:0A7M">ADL_!$6HO%AFJ\[#>/O5O+N2G_VK>;7C9J%
MCEQZ@>7?0LE(P'VFMU$QC.7B,80ZQC&,8RHF,81$1Y$'*5DH<=Y`NEGMJ=E"
MS4G8GXH4E*]OJ!5(=PCSPBY5-WQ2AN-89U+C/M'O*5%,_6=LR>^<>%Y3L@;'
MXOTFRM<]3EK.AG2+6JY:@K3JK$W2?`KJQQS:5^#KLY"V&-?`,8HKW^XT4["=
M3!T$`$/+BZ@QRY9M24>6!HV)6_Q/$6IM&B"1-:5(4-9=%"<8S:IO%)C52_8-
M_P"5DI'A[4A:IS'1*@H'3O$5`OT]?F*/PMLQ^J[B7_)KEP/S%\N7Q+9^.U']
MHBNOYQ\U]];^+L?T4/T]?F*/PMLQ^J[B7_)KC\Q?+E\2V?CM1_:(?G'S7WUO
MXNQ_11JM8-2/*_Y&M@$;1E'#N5[=E2S,Z]5YC).1:3!8MK4-7XCW&D8ZG5XV
M$K$*VBH1NZ4,H9HQ7=G)U`"*G[2\VJFS#B7CC'S2VFLI&K6VI:TLLN+?6I:M
M5!.Y2U%2B!\)02.\"<<"_C'(N9W8/7.G?76+"4EUU"&TI2-`5;0D2`[DDGTQ
M8@\Z&J^5&?CGT[P-BZFW'+\[B6S4ZM28TFMOYIZHTK5#&&6F%V,>FNHU9K.$
M/0QO3J8`Y77@O*K3\X]WOUU>9HZ>K:=6GQ%A(FMW<$@GJ91-'*=BN#N&4=JM
MS3E0^RXV"$`DR0F1,N[2,B?+28ARKA_7'8F(ROCBZ8VE9;.C23BXVZU^0KSV
M0CBX\J;07S-O((HG<-0=-SI]Y0$O>00^D.?!YEKS:;UDMN?M%2S4LHH"E2FU
M!8"O&<,B1T,B#+NCV\*VNY6JQ5;-R8<8=55[@%B1(\-`F/1,&+*'*VQ,T?.S
M\OVJ.S]^\C^SENH^O>8;=59BV12T38J[0YZ4AI)%.&8IJ*L9!JT.W<ID4*)1
M$HB`"`\[#^'LNQ:W<;VVBK[C1LU:&U;D+=2E0FH]03,14/DG&L@N&9UE70T=
M0[3**9*2@D&21.1BPMYP=!<Y[B:<:YS&#*XXMF0L`*(STEC9$4&MAM$'8:A&
MPDLW@_CW#1I]M0:K4JP-U#D%<O<0!`P!UKWP=G]CPW,;@U?7`U;K@-@>ZH;4
MAQ2DE4@3M5.4QTT/2)?Y0Q*YY-CE+^2T[JRE.XM]JDJ2D&7[Y,@9=HGVRBMG
MKQE'S::AT1SB;7RI['8SHP6&2L#BML]?J=94`L#])HSDGH2-NQU99(3+IQJ1
M1*1S[/WL!*4.HB-D\AMO!V7UXN^0/6VJKRVE.\U3J#L$RD2;=0G29^IGKK$)
MVBHY7QZC_)MH:K&*,*)VAEI6IZF:T*.LN^49W_3U^8H_"VS'ZKN)?\FN<%^8
MOER^);/QVH_M$<I^<?-??6_B[']%&[OELI6WNSWC(\8=AMF.<I9/S\[,2SYG
M;QN/S(V>/L4CC611D7MDK-:AHQA7E5GZ@$%(C1LD0X]H$`?3FB\1U^'XOR=D
MS%+4TM+CX&RG*G9H*`\"`A:U**]-9[B?3&X<B4.0W["K2I3#S]UW;G0$24"4
M]2D`!/O#WXW#\'N'LLXW\86U%-R#C6[TFW3-DRVM$5FSUV1AYR42?XW8M6*C
M".>(IN'1';H!33$@"!CAT#UYI_.%YM%SY/ME=;JEA^C0W3[EH6%)3M=),R-!
M(:GT1L'&-LN-OP2JHZYAQJK*GY(4)*.Y&DAZ8JB8`PEY(=;+[4,P84P-L'0L
MF5)FL6!L[;#Z\RO&C)1AXV0*$99ZY-0R_P`0S7.F(+-5.T#=0Z#T'EL,@OW&
M>36]VSWROM]1;'5`J0:C:#M,Q[2%I4)'N4(@&UV7/+'7BY6FDJVJQ$PE8:!T
M.AT6"-1WB)&_T]?F*/PMLQ^J[B7_`":Y'/YB^7+XEL_':C^T1MWYQ\U]];^+
ML?T4>4QWS^8C._CR+RVRPMU)!BFX`VKV)BE^'.[1(X[C%PV!B%]D3=1`0Z!Z
M]0YXN8+Y<PVHI3;-VTR_\VHZRT_^1'DC(^:BL!1K=LQ/_P`=C^BB2CYFC!F:
M,QV/517$N*,@9*3@XZ]A,J4FKREA)%BZ.U^&*_-'(+%;&7[1[`-T[NGIR,_+
M-?K)96;J+O5T],7"UM\181NE.<I]91N_-MFNMV_)_P"3*=U_PRYNV)G*>V4_
M7^Y$HO@9H%ZQEXX\:U'(U/L=%M+*WY`6>5VUQ+N%F6R+J;!5LJLP>II.$TW"
M0]Q!$.A@Y%W.]QH+IR/5UMM>;?I%--26A04DR1(R([C&\\6T57;\+IJ2N;6U
M4I4Y-*A(B:R1IZ1&(O-CXEF&\./%,W86AF3/:;&<(Y,Q;-D6S0V8JHR24<J4
M:3<B*!#V1KV=T(Y7.)2JB+8XD36]Q/F>$^6G,%N/Y%O*U*Q6J6-TR3\G<.GB
MI&OLG^4`ZCVA,ID>-Y,X_;RNA_*%O2$WYA)V]GBI'\FKT_$)Z'3H8KS>'3Q8
M;>VS=+"F:<A8CN.'<4X"R!%Y'G+1D",^P5YR;J#P%XZH5V&=G"4DG<@]`"KK
M^TFV0;]5"J'-T(-AN8^5L/IL+K;+;*QFMNM?3EE*&CN"4N"2G%J&@`'03)*I
M"0$S$0<<<>Y$YDE-=+C3N4U#2NAPE8D5*004I2.V9Z^@$SZ3^@5SK^BVD0`?
M,@8NR5ES1"@5G%E"MN1;&UVBQY-.8*F0CV?E6\.TQ[EQJZE%63!)58C%NZ?H
M)G4$.TIUB`(]3!R?_+A=K99\[J*J[5#--3&UO)"G%!*2HO4Y"9GM(!,O08B7
MF6VW"ZXJU36UEQ]\5S:BE`F=H;>!,NZ9`]T1KA\L;A?+V',?;AM,M8QO.-'4
M_D+%#N#;W>N25=6EVK&I61!ZXCDY%%$SM%JLL0JAB=0*8X`/J/-C\S=\LUZN
M-G79ZIBJ0W3OA1;6%[27$$`RZ3$Y1Q/"=IN=IHJ]%S8=86MQH@+21.0<G+OE
M,=.^+1W*NQ.$.(0XA'B/X]A*LG,;*,FDE'/43MWC!^V1>,G;=0.BB#EJX(H@
MNB</02G*)1#Z0YXK0AQ!;<`4@B1!$P1W$'K'NIZFHHWT55(XMJI;4%)6A12I
M)'0I4D@@CL(,XTEO_C0T(RC*FF[UJMB2<DS&4,+@(%2+)U6-WJ=K:&=1S0I1
M-Z@`$``^YTYJ5;@.&7!WQJJW4RG>\)V_6%,3SCGFH\Q.)T?R#'\OO-/2Z:>,
M'.F@]IU*U?LQZR`\7/CZK+U"0B-4\5INFHH_#'?1TC,)M@;JE62*W;S$F_;H
M$*H4![2$`H_0("'/33\=812J"V;;3;A*4P52EW!1('N1]5Q\VOF1NK"J:MS"
M[EE<]P0M#15,2.XM(0HF7:22.R/0;.7WQXZ"8J=7S,5'P?28EJT,%<J;"@4Q
MY=KF]9H`DVBJI72QII:8<F%,J9EQ`&S<3`9=9,H]W)'P[BM>87%-IQNU4ZU3
M&Y?@H#;8^,XO;)(`[)[C]2"8A;+>=<TME.N[Y+DUXF9D`UM05K)))"$!S4DG
ML$A/60BAYL1F#)?ELW:K,#AG#->H"-UEF%$Q3BRD0<7%I0-40?.'#ZY7UY#-
MV[)[-H,G2S^7>AT0;H)$;(BH*9#K=A&"\?X)P)BU1>5-4R*X-A=74I;2A3Q3
M\!E$@#LW$I;3*9*BM4NB:8Y[RER;SI<:;&KE<[E5V5EU9I*9^H<>;8*P`M\[
MU*DLI2-QG)(`2F6I5-AHUE3+WC+\@49HY8+^_O.'92[53$LG"F%=2"-/7AE$
M-JO<*FP<BY<5M1"US)$5TB&(DLT]TQTP.8IR]+U1G^24?-]T3?*E=32W:ZJ4
MH*F9%]0#"DB:MA2-C:@#MD"8_1GE?"7&G*_DBLF:8C:J>UY'CN,)=9<;`2LH
MH$K-:R\I(0'TNAMYY"E)*TK4@!1`4DV<=S=OZKI;C&M9)L^.LEY66N64\?8>
MJE%Q,UJ#NXSMTR7.)5^M-6A;S;Z/74FQY!8H*J+2"?87U`#?1RP\=/8$S*.+
M"VTUMR?`Y)L5_P!3-CM;6&.H,T\4,UEPN9:Y-4&4B_?H50N+LP9*(=S'(Q_1
M4'YF)!,L3L,<.X2H2[C&O&K7DPE=LPQ?8:#HEN3`XDRNN^&"S?<$-<&F/(Z)
M8+S#)2?FFT)L/.WE",4DH51L0J,,NY%10@BD"8B<,`SC*D[3(D3CR<V^2EQC
M79ZYZHXQTZV=V6R#C7'^/,H9`E,1#A)G6H*HY(=V%E"@U7R/F"C2TI.IKUU7
MO;%:$1Z'+T7'ZW:G#;I.8`C-VJ&]&'-NHK(B5.CKW0,EX<EOL+,.#,N5A2E9
M>QI*J-!?L$[!757+QB\C9AET5924<[?1CHH_>W!A`0#,XP4D>J->,`^4)_LJ
MXKDKBS0_<Z5Q99;];*"TS6Z:ZW,\>M5Z-=9_']HL#Q`VQ)[N6`BK-67:)C$A
MU'1P3[B(&`>8G&2F6A(G'9M@?(XXP_LM-:KXXU#V5V:R14</5#/%T6PZ?"S.
M%@\>7.QW*IQOPJF2LN424FK.6:IJH"Q;M1(9%8ABK"(&*5.`3,3F(V?U.VFQ
M?N3A*MYVQ(-@0K,\[F(=]"6V&6@+75+16Y!:)LM3LT4H==)K-P,H@=!<$%G#
M<3!U35.40-S/6,$%)D8U]TW\FNO&\&7=D<-8A9WEC9-:[8YKLQ(VV+AH^"R+
M"-YF1KH9"QFZC)^8>3%'<3T2X:$</4(]S[R0@*`?3S`,XRI!2`3VQG[]*&C_
M`*73C37[#MG]HS?7Z#V-/8_A8?\`$@U/G[_;\=M8<KW[:^WALR4O3'*RB8QX
M-0;*)"#@QQ.F3,8EI/TQLIQ&(C>V%\B;3%>?7FK6%=<,V;:9YKF.&F6\AT_$
M"F.X*-QI09-Z+&#D;9:,I7>B0IY6RJIG^SHY@H]>.`3,/87TZXGV1Y!.FXF0
MC-^6=R,5X`U@CMIL],;;B.LOZY4I,V/[/$MGN5&]NNK5J:!Q.C5JQ(3Z,UDY
MW+.PCBQ\<Y>$4>%,":ITRBIQ/2<`DE6T1IXP\LS"GV_%$1M/IWM)I_0\[6*&
MJ>*\P9@C\72U!<VFSJJ-ZE4[^KC/)-YF\76NU."@DR9S3-L)E>I5#)B`=R<9
MV&1D091N_=MI*-1-HL':GRD';75]SWC[+F1JI/Q[6&4I\5#X;7I;>QL[$[<S
M;6:;R<B>\-18E;,721P25]U1+H3OS/64>,O9W=@CEV9V>I&K%=QQ9;U"6N=9
M9-S;BK!,(A4FL.Z=,K3ERTLZE7Y25+,S4(BE7X^0>E4>J(G6<D1`1215-T**
M`$X\3..U5$P'E'6?$]K@K=*SVTN1)K&M&?UUI#.(>"F8.O'L;EY;59*;BWK6
M+59D$B9F:#U45?04RE^MQ`"8)[HT\V3\ICS5ZY1=7O6AFZ4Q$6S+D/A'&]]J
MK76MU4LF7VQ1TO*UYA5"RVQD-9$6\PQ@'ITE9*/8`3X8P*=@F(!L3C(3/H1&
M:;-OI$8YQ7AK)F8M>\^8@?YJV,QCK7!8VN+;%3R]0-JRS=8NCU>T63\4,HV>
MII4T)&4*LNJSE'CXC8AA*U.?M(.8P!/IW1[;;3>W'FJMDQGB]*B9,SOL#F=2
M3-BW7["D1#S.1++$P8%&P6U\M9)NLU6ITFOBH4'DK*R+1JF8W:03J?4Y@F,I
M23KV1TS7'R)5;,V=IW57*N$LQZI[-0U4/>XW%.:VM,<IY`I+5T+.4M>+[QCF
MW7BD7>'@W0D2?"W?%6;JFZ"F)0$W$X%,A/J(\C$?DOUVR]O%L+X_8Y.X57/6
MO2,2Z>EM["#CZODMD^J]2MDNXQA*,+!)O9E2J1]XC0D6SUK'NR"L*B22J":B
MI4]90*2$A788R!0]YL,W7'.U^5WK>U4FBZ;Y!S#0,O35JC6!@`<(5]O9[M:*
M\UKLI/O)&N$AUA4;^X1!\J*9@%N4>WNS&)&8'?&,M4-\[SM+.4QV72'9W$.'
M<H5%_>,:YQR4KAHE4FX!L@FZC#S]:J^5+%D&F/;0U6(K&HOXE,RQ#`)^PH@8
M<3C)3+M$XD8YF/&'$(_)SD3*)U#E(0/I,<P%*'_B8P@`<R`3H.L(T"V<\H>C
M&HQ7S3,>?Z<UM,>;VUL?5-T-WR$"@E$2`I3JP$E--4CGZ%]U9)-(HC]8P!U$
M-]QCC#.<N*566WO*I5?RJQX;7W1<DGU`DQJM[S;%\>!%TJVDO#ZA)WN?\"9J
M_8E%:#<7YG;)-N1E:?IABY'&T6M[S0N5\HD:35L4(515(7=>IC-5:(CT7K4P
M&34?+?%-S]!]L!`0Y9C#O+#;Z52*S-*KY0X)'P&)I1TZ+</M&1Z[!(]\0GDG
M.;[J54^,L>&.GBN@$]3JE'03&HW3E/I/2(+L6XAW=\I.>U(^#6R!GO)DHHV7
MM5_N<D_>5RE1*ZOPR<O:9YP`15<AT`3$B*9?;.L*?M)%,?H')UNMXP;BNP;W
MA3T%M3,-M-@!;JAKM0D>TM7:2=!.9D(BF@MV5\@W?:@O554?A.+)V-I[U*Z)
M'<!J>@BX9@7733CP(:_2F1,C62+R;L]>8<6SB:(@V3MUQDD&Z"QZ5C:'6[GL
M#0V$DH!G#PY2"<AB*.3=XD3YUQ\]^88WE)K+JOY-9&BKY-1I5-;BNQ2A]4LB
M6Y7P4=GI[&?*OY2LGY"OJ+!B+"G'24&ON3B"&*9L]9JE(=%>&T#O=(G+0D1+
M:#U+)_D(\FD=G.VMQ`D'D=GL!D.49)&2BZZWID@Q?TBO->SJG]^E8R-8%3*(
MB<@J+"':!A"A&#TMQSWD87RK'L-OBI<(^"CPR"T@?[P2)=NICO+\Q-YQ/RV>
M51WC^S*]JHM:K/1MJ,W'C4H6BJ>5VZ-N/NDGH=J.LA$^GFUKDC;\$:P5>)L=
MDILC/>0'3Z+:7*GG%*T5-9WE)@D2Q0+CM,1M*19A]Q%0WU2'`!'EQS'02DR,
M_1&V]*UZMV!<-YW9V?8O->PRMBI%I=,G&8YEE-N:\5M4Y-`S*$^":-O:;O3C
MWJ%'N$Q^(3F1V17C\+U]U9KE4TV1F/*YFL,MIGL<4?1R7R^W#&)K%+R%\A65
M&7QV>+^*3:-4GZ<HU;"N`@[226^CTY@1[')S.FG?&\$[N!K7J'YH]U9K9'+M
M4Q)'6[3K4Q"J+VMTHS"R.HN?RFH^90A2I*&D7R!3A]Z3`QQZ_1S/;'C(E``Z
MSC(^C86+9??#<[R(US&-KQIKMD/`F,=>\03.0*C-46X9T/0'LO8YG+[>M3C5
ME))TP3218V)<N4DUG**(F``*'0`ZS@J02$]L19^*S(.K%,C\0GR#Y6\UXIRC
M&;*9]37TA_M;0A,5J2$ILCEMO7:HYQ\M%J.31E[9R;6:53]XOQ+U^94/0P=<
M#UQY+GK[,;X;!X$SAGSS"[+5W!6T>0M5+:CXUL"$97"D5V%G$9>1>9BV`;QC
M>7--IJ`W;1;TY%NYJ`N"@(B'0>WCMC`("-1/6,7:V[4I:S^!&5G,4TM]6]D8
M"<R+J\UK:2KN0L-EW7MN2'>,CW!TI+)I24L[F;U8F]@>'6*!@:`<1Z)DZ\=D
M")N:]/W(Q-4];]FO$GG#QM9ORI8\-V7!T%#POC]RJ_Q-`VB`>I5O+$B>5IF2
M<H+238"V27:92644.Y`#',N],8>A3&$&HC,TK!`]>L;E[0;?Z[Z:>:YI?-DL
MB,\9U2T>,_'U;@9F2CY1XSD)QMLMG9^O'$4CFCH4UR,S@?H(=1`0_=YGH8\0
M"I&G?$WV$LTXTV*Q72\UX=L[6Y8SR%%GF:A9V2+ENUF(U-Z[CCN447B+=RF4
MKQBJ3H<A1ZEYF/61+0Q`UY2Y[0FI[$63([W=/).B'D!H.&(QK#WC'!;$1QEB
MAOU'LS5*;,T0T6Y@,XL$IUF1/X)L*SYIW"B':*@!S!E[L>Q.Z4I323'I=BGV
MWN;/'CXSMTLVX6G[GDS7+,V%-GMG\#56K&:6>W4N)8OFD_:8W'ZJ9E4IZNLG
MZ5@&#22462.!TDB_>^G'9.`EN*1I.//\A.\VMWD?UP9:8:3S1=FLZ;"W;$2;
M".I\!,NT,#UVOY"J]TM&6,JR+N,11QTA38B#6;F3=J-WYGCCV$RB<#E#!,]!
M&4I*3N5H!'<]]-@\-::>33QD9'V&O;:D4&OZL;D4]];WC&3>L33CE?7=DQ15
M^";NETS2"S8PE$P=>9/6,)$T$#O$=A\@^QN.-NM#:'M;J@ZD]@\::[[AX!S!
M=TJ!#RKF><U+!F6(*9R<>&B7+-!Z]=UF&35=*$*F/>DB;MZCTXC`$C(Z&4=2
MR5M7A/R+[V^-6(TRM89SC<`7_(&P&<KC5H^2"G8HHSRCIUN`8W&=>LVS*.N-
MHFG1D640)_CA]A0QTRE`!%U,9`*4F?;&S/F`(J>-\<GM)JJ"3RC:YJ']I,Z@
MIIEQSG8#*']LINQ,HB'4P]`#KP8-]3ZHY?,*FHI2=&_;255$ODZT/.<$DSJ"
M1,N>ZH)U#@0INQ,@>IC#T``^D>#&$=OJ,8:V=OT/HYY6:UNAL%"2B&KN9=5V
MVNJ6<FT._FZW@')<!>SVU%M>U6+5ZXJ=?R+&F!%.3$J;3WT@35.'KQT,^R,C
MVD[1U$=3=Y5I7DF\H&E^2M2#2=TPGI#`9EM&9]H*^Q>,<=6">RC`0<%5<!U^
MS.6C5.ZO2@Q4EI%%F==LQ[DP5$JG4..IA(I29]O9&MLQIM:]F=E/+)DK!\@G
M1]Q-7]X,-9EU7R(H!V0*6F+U0Q26?Q?//NA`=X\R[$HC#RZ!C&0ZF24/_$CS
M$HR%2`!Z$1F;Q09<J61-$_))FS;'&,C2:3<MH=M++L3B2>KTI.NXJ"&GP47E
M.I*UN,;.92?:OF[)\F@V:I*JNVZY")`83`',CIK&%#V@$]8QIH+ENDXWW8P+
MK7XX]OLB[>:76C']_DLLXANZ[_(L#J'7JW#`YQTZK&7Y1JE*UTDY9%U&!:T]
M.942`42!Z`(8'73I&53()4/:G%H;GE'JAQ",);(86C-BL$Y3PC+RTG`-,D4Z
M6K9)V&>NXZ3A7KM`31LHU=L54'1!92":9SD(<OO)`9,?JG$.<UCMY=QZ^4M[
M90AQ=,\E>U0!2H`ZI(((U$QZ#KV1Q]VMZ+K;7[<XI2$O-E.Y)(*21H01(Z'7
MT](^7O(:9;,I;#7S5VMXBOF0<P4"Z3%-EX2JUY](*.74<OW(2RCOL)',VDO&
M+HOBF56(!4EP]?0>=H3.:XPK'*?*:FK8I[14,)<2I:P)`C5,NI*2"G0=1%&'
M\4OJ;V]8J>G=>KVG"DA*29Z]9])'0S)[9Q-1@KP?XSPDP8Y6\JFQ]$PC5D#)
M.&V#*3;&;Z]3Z@"V7;QU@L38BSE@2135%$S2-;E=D5'I\23IUY5GE'S?XMC-
M,MC'%M)<Z?**C0`ZC[4Q/<HSZ%<TGXL6KX9\F/)_*5P0S;[57UZC(ENF0K8$
MZ3+M09(2D"95M5,`=>_=N]^8W"^MN."8%\8^`8'&=-8>^5*_VBOI,0.[5*0J
MTXSJBWNO)JPJJD,91]-J//B@,`G)U]>=:/(GF6NV25SE50*=JK@O0U-3/0=@
M;:Z`#ZD'V)?4QW3\%?Z8MOL;#-3RS5-,T2"%"VV]0DHZD^/5#4A4_:\+:X"#
M[9B+_$V%MO?)GG-ZNQ>V3)-NE'"![OE:ZN7JU5I,.994Y3R,B<?AVD>P*=0&
M42R[?7M12(F4Q1""+59\KY(O16%.5%02/$?<GL;3,]3T`&NUM/J`$7YS'.N%
MO*IQ^VW4-TMKLK*3\EM]*E(J*IP`#V$#52UZ>+4.S[5K*B"(NWZ3Z78MTAQ`
MSQICUN,C-R0M93(=\?HIEGKW9DD#)&D7YR!T;QK$%E$V#(G1%HB<P%#O.H<]
MQ<0Q*V8=:DVVWB;AD77#\)Q<NI/<-=J>B1TU))Z%^>.=,NY\S5>59*KPJ!K<
MW14B"?!I&"9[$`_"6N0+SI]IQ0$SM2E*=P^;5$)PXA#B$.(0XA#B$.(0XA#B
M$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$0*>;1]LKA#%
M,1F+6N]/,8T6<G#5_8%.A5^O0MHFWTPBW9T^XS-X:11+2DU:*-1BS"5V"@JO
M&P%,4H"`Q!S1<\QH;)3UUGK7V[4R2VZ@:[0L^RI*C,H3N]DA,IJ4DSZQ?_R`
MX_PKEF=5^+\A62CKLO=:34V]U\K4A7@@^.P6-P:=<*"'DEQ"@&VG`0=)5#HR
M)R5FR])LHEC>LN9)G5DDA!()Z]6]^=PH"::CY\N:2DB-14/T,NY5(@3KU,<H
M>O*D--7.]UH0T'ZNX+,OJG%F?>3,@>DD#TQW9U=9BV!X^7ZQRWV7%J=).OA4
ME,@`3(0@;$%4AHE"2H]@)B?W2[P(9`NJL3>=PI9?'%7'M=%Q)67;1W>Y0@@!
MB-[+8DC/(:L)`H42K(-2OUE4S?561-ZA.F(<'UE445V6++-/U\!!!</H6O4)
M](3N/<H1UR\Z?ZB>-V%#V/\`"C*;I=_@_E%]*DTC9[2PR=KKYE(I6X6DI(U;
M<$6E,2X<QA@FE1>.\1TJ"HE/B$RE:Q$&T!`JRH)II&>R+M057TM)+)I%!1RZ
M56<*`4`,<0`.EDK9:K=9J--!:V4,TB!HE(E[I/4GO)))[3'4CF6;Y9R#?7<E
MS.OJ+A>WC[3CJIR$R=J$B2&T`DR0VE*!,R2)F,E\Y"-5AQ"'$(<0AQ"'$(<0
MAQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0C">Q
MZ6&U\$Y40V$<Q++"RU.EDLB/)HJAV32OJ)`15RF5!N[=FDD'`IF9`W25<B\!
M+V2&5[`'B;\+4;-4B^%`M!95XI5T"):GM,_BR!.Z4M91OG&"\X;Y"M#G&R'E
MYTFN;-$EJ6Y3P,PDS*4["G<'=ZDH\+?XA"-QC7C1LF@"5$;IZ0+8C<0"9%".
M'%/`A;<N8A$BNEILLXDA<@%4P`8X."$2[Q'H4/4.<%AHPD4`&'&E--+^3^'V
M?"W?;/\`B[8DKG]7F-7D*E<^)O*;B2"!4S^3#4[0UX1--IT&PE4I3)T,;Y\W
M.*\PXA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0
..XA#B$.(0XA#B$.(1_]D_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
